Icure Pharmaceutical Incorporation (KOSDAQ:175250)
2,170.00
+231.00 (11.91%)
At close: Aug 5, 2025
KOSDAQ:175250 Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8,270 | 17,184 | 6,332 | 50,569 | 17,806 |
Short-Term Investments | 2,740 | 5,250 | 340.19 | 360.19 | 745 |
Trading Asset Securities | - | 2.19 | 1,886 | 2,856 | 5,866 |
Cash & Short-Term Investments | 11,010 | 22,437 | 8,558 | 53,786 | 24,417 |
Cash Growth | -50.93% | 162.17% | -84.09% | 120.28% | 77.99% |
Accounts Receivable | 12,999 | 10,582 | 7,726 | 8,174 | 10,153 |
Other Receivables | 208.85 | 729.74 | 194.11 | 509.92 | 1,774 |
Receivables | 13,208 | 12,772 | 8,760 | 15,884 | 16,978 |
Inventory | 8,920 | 12,897 | 13,019 | 10,546 | 16,977 |
Prepaid Expenses | 134.45 | 139.83 | 116.21 | 80.58 | 129.48 |
Other Current Assets | 1,164 | 326.62 | 654.81 | 408.36 | 294.83 |
Total Current Assets | 34,436 | 48,572 | 31,108 | 80,705 | 58,796 |
Property, Plant & Equipment | 48,794 | 64,529 | 93,526 | 96,943 | 101,312 |
Long-Term Investments | 871.97 | 1,659 | 9,416 | 11,001 | 22,675 |
Goodwill | - | 1,601 | 2,858 | 2,858 | 4,150 |
Other Intangible Assets | 425.92 | 1,829 | 2,381 | 2,980 | 3,081 |
Long-Term Accounts Receivable | - | 83.93 | - | - | - |
Long-Term Deferred Tax Assets | - | 1,172 | 774.48 | 530.59 | - |
Long-Term Deferred Charges | - | 5,030 | 9,020 | 9,701 | 8,622 |
Other Long-Term Assets | 4,661 | 8,526 | 17,144 | 18,412 | 16,794 |
Total Assets | 90,500 | 133,618 | 166,844 | 224,121 | 215,448 |
Accounts Payable | 8,166 | 6,685 | 7,291 | 6,461 | 6,155 |
Accrued Expenses | 513.9 | 700.15 | 755.32 | 718.82 | 496.54 |
Short-Term Debt | 20,540 | 32,169 | 56,276 | 73,521 | 10,050 |
Current Portion of Long-Term Debt | 1,019 | 1,556 | 12,766 | 3,747 | 32,120 |
Current Portion of Leases | 1,311 | 1,234 | 77.56 | 171.09 | 185.44 |
Current Unearned Revenue | - | 242.6 | 106.08 | 23.75 | - |
Other Current Liabilities | 23,916 | 21,747 | 15,774 | 25,339 | 5,811 |
Total Current Liabilities | 55,466 | 64,333 | 93,045 | 109,981 | 54,818 |
Long-Term Debt | 666.63 | 4,352 | 4,862 | 9,450 | 31,650 |
Long-Term Leases | 4,118 | 1,129 | 34.72 | 120.83 | 180.31 |
Pension & Post-Retirement Benefits | 508.82 | - | 5,907 | 2,878 | 2,465 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 16.36 |
Other Long-Term Liabilities | 2,220 | 2,112 | 2,852 | 9,833 | 27,615 |
Total Liabilities | 62,980 | 71,927 | 106,700 | 132,262 | 116,744 |
Common Stock | 18,779 | 18,779 | 18,779 | 18,779 | 9,446 |
Additional Paid-In Capital | 134,882 | 133,428 | 133,401 | 133,434 | 107,271 |
Retained Earnings | -124,907 | -91,382 | -93,734 | -60,603 | -18,969 |
Treasury Stock | -3,707 | -3,707 | -3,707 | -3,707 | -3,160 |
Comprehensive Income & Other | 1,298 | 1,394 | 1,657 | 1,769 | 1,168 |
Total Common Equity | 26,345 | 58,512 | 56,395 | 89,671 | 95,755 |
Minority Interest | -1,888 | 471.81 | 1,355 | 2,188 | 2,949 |
Shareholders' Equity | 27,520 | 61,691 | 60,144 | 91,859 | 98,704 |
Total Liabilities & Equity | 90,500 | 133,618 | 166,844 | 224,121 | 215,448 |
Total Debt | 27,655 | 40,440 | 74,015 | 87,009 | 74,186 |
Net Cash (Debt) | -16,645 | -18,003 | -65,457 | -33,224 | -49,769 |
Net Cash Per Share | -444.36 | -481.04 | -1742.81 | -1426.23 | -2298.37 |
Filing Date Shares Outstanding | 37.05 | 37.37 | 37.37 | 37.37 | 22.51 |
Total Common Shares Outstanding | 37.05 | 37.37 | 37.37 | 37.37 | 22.51 |
Working Capital | -21,030 | -15,762 | -61,937 | -29,276 | 3,979 |
Book Value Per Share | 711.00 | 1565.77 | 1509.11 | 2399.56 | 4254.76 |
Tangible Book Value | 25,919 | 55,081 | 51,156 | 83,832 | 88,524 |
Tangible Book Value Per Share | 699.51 | 1473.96 | 1368.91 | 2243.32 | 3933.45 |
Land | 5,674 | 8,305 | 25,626 | 24,378 | 25,388 |
Buildings | 38,860 | 47,346 | 52,384 | 52,053 | 50,835 |
Machinery | 22,227 | 32,627 | 36,265 | 33,830 | 30,572 |
Construction In Progress | 395.4 | 1,209 | 259.66 | 917.82 | 3,422 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.